BAX Stock May Rise Following the Launch of FDA-Approved Hemopatch Pad

Baxter International (BAX) announced the launch of Hemopatch Sealing Hemostat in the United States. This innovative, ready-to-use collagen pad is designed for hemostasis and sealing during surgical procedures, making it suitable for both open and minimally invasive surgeries. Hemopatch is unique as it can be stored at room temperature and is activated upon contact with moisture, offering enhanced convenience and efficiency in the operating room.With surgical bleeding and leakage continuing to present signif ...